This two-and-half-day event will consist of an executive forum, keynote sessions and three different tracks to assess how the senior management and operational challenges, quality system effectiveness and regulatory changes can be brought into a new pharmaceutical paradigm to exploit opportunities like Quality-by-Design, continuous manufacturing, science- and risk-based regulations in the daily life.